亚洲社会药学

centralized drug procurement, stakeholder, policy evaluation

Objective To construct an index system for evaluating the policy effect of centralized drug procurement, and to provide reference for comprehensively and systematically evaluating the policy of centralized drug procurement. Methods Through combing the policies and literature research, the focus and expected goal of China’s centralized drug procurement policy were clarified. On the basis of policy concerns, combined with some theories and the implementation of drug centralized procurement policy, a primary evaluation index system was constructed. The index system was determined by expert consultation, and the weight of each index was calculated by analytic hierarchy process. Results and Conclusion The questionnaire recovery rates of the two rounds of expert consultation were 88.23% and 100%, the coefficients of authority of experts were 0.86 and 0.80, and the expert coordination coefficients were 0.338 and 0.294, respectively. Finally, the evaluation index system for the policy of centralized drug procurement was established, which included 4 first-level indicators, 10 second-level indicators and 23 third-level indicators. The evaluation index system constructed in this paper can not only make up for the deficiency of systematic evaluation of the policy effect of the current centralized drug procurement, but also provide reference for further improving this policy.

centralized drug procurement, stakeholder, policy evaluation